These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
201 related items for PubMed ID: 9286768
1. Tumor-induced osteomalacia: clinical and basic studies. Shane E, Parisien M, Henderson JE, Dempster DW, Feldman F, Hardy MA, Tohme JF, Karaplis AC, Clemens TL. J Bone Miner Res; 1997 Sep; 12(9):1502-11. PubMed ID: 9286768 [Abstract] [Full Text] [Related]
2. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)]. Lorenzo Sellares V, Torregrosa V. Nefrologia; 2008 Sep; 28 Suppl 3():67-78. PubMed ID: 19018742 [Abstract] [Full Text] [Related]
3. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol. Harrell RM, Lyles KW, Harrelson JM, Friedman NE, Drezner MK. J Clin Invest; 1985 Jun; 75(6):1858-68. PubMed ID: 3839245 [Abstract] [Full Text] [Related]
4. Hemangiopericytoma-induced osteomalacia: tumor transplantation in nude mice causes hypophosphatemia and tumor extracts inhibit renal 25-hydroxyvitamin D 1-hydroxylase activity. Miyauchi A, Fukase M, Tsutsumi M, Fujita T. J Clin Endocrinol Metab; 1988 Jul; 67(1):46-53. PubMed ID: 2837500 [Abstract] [Full Text] [Related]
5. Vitamin D metabolites and bone mineralization in man. Bordier P, Rasmussen H, Marie P, Miravet L, Gueris J, Ryckwaert A. J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606 [Abstract] [Full Text] [Related]
6. Tumor-induced osteomalacia. Kinetics of calcium, phosphorus, and vitamin D metabolism and characteristics of bone histomorphometry. Siris ES, Clemens TL, Dempster DW, Shane E, Segre GV, Lindsay R, Bilezikian JP. Am J Med; 1987 Feb; 82(2):307-12. PubMed ID: 3812526 [Abstract] [Full Text] [Related]
7. The role of insulin in the stimulation of renal 1,25-dihydroxyvitamin D synthesis by parathyroid hormone in rats. Ikeda K, Matsumoto T, Morita K, Yamato H, Takahashi H, Ezawa I, Ogata E. Endocrinology; 1987 Nov; 121(5):1721-6. PubMed ID: 3311717 [Abstract] [Full Text] [Related]
9. Cinacalcet in the management of tumor-induced osteomalacia. Geller JL, Khosravi A, Kelly MH, Riminucci M, Adams JS, Collins MT. J Bone Miner Res; 2007 Jun; 22(6):931-7. PubMed ID: 17352646 [Abstract] [Full Text] [Related]
10. Tumor-induced hypophosphatemic osteomalacia associated with tertiary hyperparathyroidism: a case report. Tartaglia F, Minisola S, Sgueglia M, Blasi S, Brunelli D, Degli Effetti E, Maturo A, Cola A, Custureri F, Campana FP. G Chir; 2006 Jun; 27(1-2):9-13. PubMed ID: 16608626 [Abstract] [Full Text] [Related]
11. A patient with primary hyperparathyroidism associated with osteomalacia: markedly increased serum levels of intact PTH and 1,25-dihydroxyvitamin D with normo- and hypercalcemia. Takemia T, Sato K, Miyata M, Imaki T, Shibasaki T, Tsushima T, Demura H, Tanaka R, Obara T, Oguchi S. Endocr J; 1993 Feb; 40(1):121-6. PubMed ID: 7951485 [Abstract] [Full Text] [Related]
12. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia. Drezner MK, Lyles KW, Haussler MR, Harrelson JM. J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520 [Abstract] [Full Text] [Related]
13. Normalization of mineral homeostasis after reversal of osteopetrosis. Nesbitt T, Marks SC, Jackson ME, Mackay CA, Drezner MK. J Bone Miner Res; 1995 Jul; 10(7):1116-21. PubMed ID: 7484288 [Abstract] [Full Text] [Related]
14. Vitamin D physiology. Lips P. Prog Biophys Mol Biol; 2006 Sep; 92(1):4-8. PubMed ID: 16563471 [Abstract] [Full Text] [Related]
15. Hypophosphatemic rickets/osteomalacia in linear sebaceous nevus syndrome: a variant of tumor-induced osteomalacia. Carey DE, Drezner MK, Hamdan JA, Mange M, Ahmad MS, Mubarak S, Nyhan WL. J Pediatr; 1986 Dec; 109(6):994-1000. PubMed ID: 3023599 [Abstract] [Full Text] [Related]
16. Serum osteocalcin is increased in patients with osteomalacia: correlations with biochemical and histomorphometric findings. Demiaux B, Arlot ME, Chapuy MC, Meunier PJ, Delmas PD. J Clin Endocrinol Metab; 1992 May; 74(5):1146-51. PubMed ID: 1569162 [Abstract] [Full Text] [Related]
17. Effects of infusion of human parathyroid hormone-related protein-(1-40) in nude mice: histomorphometric and biochemical investigations. Rosol TJ, Capen CC, Horst RL. J Bone Miner Res; 1988 Dec; 3(6):699-706. PubMed ID: 2855193 [Abstract] [Full Text] [Related]
18. Parathyroid hormone effects on serum 1,25-dihydroxyvitamin D levels in patients with X-linked hypophosphatemic rickets: evidence for abnormal 25-hydroxyvitamin D-1-hydroxylase activity. Lyles KW, Drezner MK. J Clin Endocrinol Metab; 1982 Mar; 54(3):638-44. PubMed ID: 6276432 [Abstract] [Full Text] [Related]
19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L. Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [Abstract] [Full Text] [Related]
20. Oncogenic hypophosphatemic osteomalacia associated with a nasal hemangiopericytoma. Fuentealba C, Pinto D, Ballesteros F, Pacheco D, Boettiger O, Soto N, Fernandez W, Gabler F, Gonzales G, Reginato AJ. J Clin Rheumatol; 2003 Dec; 9(6):373-9. PubMed ID: 17043447 [Abstract] [Full Text] [Related] Page: [Next] [New Search]